{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:30Z","timestamp":1753892010544,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Malignant ascites (MA) is a common complication of terminal cancer, which seriously affects the life quality and prognosis of patients. Both hyperthermic intraperitoneal chemotherapy (HIPEC) and traditional Chinese medicine (TCM) preparations have achieved significant efficacy in the treatment of MA. The treatment strategy of TCM combined with HIPEC has been gradually promoted and applied in China. The purpose of this systematic review and meta-analysis was to assess the efficacy of TCM combined with HIPEC in the treatment of MA.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Randomized controlled trials (RCTs) of TCM combined with HIPEC for MA were searched from seven electronic databases. Two researchers used the Cochrane Collaboration\u2019s tool to assess the risk of bias. Excel 2019 was used to establish a database for information extraction, RevMan 5.4 software was used to analyze the included test data, and STATA v16.0 was used to conduct Egger\u2019s test to further detect publication bias.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 19 studies involving 1,504 patients were included in this meta-analysis. The results showed that compared with the single use of HIPEC, TCM combined with HIPEC could significantly improve the clinical efficacy (RR = 1.51, 95% CI [1.40, 1.63], <jats:italic>p<\/jats:italic> &amp;lt; 0.00001) and karnofsky performance status (KPS) score (MD = 8.16, 95% CI [6.46, 9.85], <jats:italic>p<\/jats:italic> &amp;lt; 0.00001), reduce the ascites volume (MD = \u2212156.98, 95% CI [\u2212213.71, \u2212100.25], <jats:italic>p<\/jats:italic> &amp;lt; 0.00001). However, there was no statistical significance in reducing abdominal circumference between TCM combined with HIPEC and HIPEC alone (MD = \u22121.8, 95% CI [\u22124.57, \u22120.97], <jats:italic>p<\/jats:italic> = 0.2).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This study found that TCM combined with HIPEC had a beneficial therapeutic effect on MA. However, more standard, double-blind, multicenter RCTs are needed to further confirm the efficacy of TCM combined with HIPEC in the treatment of MA.<\/jats:p><jats:p><jats:bold>Systematic Review Registration:<\/jats:bold><jats:ext-link>https:\/\/www.crd.york.ac.uk\/<\/jats:ext-link>, identifier CRD42022319993.<\/jats:p>","DOI":"10.3389\/fphar.2022.938472","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T04:59:25Z","timestamp":1661749165000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The efficacy of traditional chinese medicine combined with hyperthermic intraperitoneal chemotherapy for malignant ascites: A systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhixian","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ejca.2005.11.018","article-title":"Malignant ascites: systematic review and guideline for treatment","volume":"42","author":"Becker","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.13638\/j.issn.1671-4040.2020.13.002","article-title":"Improvement of therapeutic effect of jianpilishui decoction combined with intraperitoneal hyperthermic perfusion chemotherapy for malignant ascites: a randomized controlled study","volume":"20","author":"Cai","year":"2020","journal-title":"Pract. Clin. J. Integr. Traditional Chin. West. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-012-0396-6","article-title":"Malignant ascites: Pathophysiology and treatment","volume":"18","author":"Cavazzoni","year":"2013","journal-title":"Int. J. Clin. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3969\/j.issn.1004-745X.2017.08.055","article-title":"Clinical observation on the curative effect of wenyang Supplementing Qi traditional Chinese medicine in the treatment of secondary peritoneal effusion of advanced ovarian cancer","volume":"26","author":"Chen","year":"2017","journal-title":"J. Emerg. Traditional Chin. Med."},{"volume-title":"Review manager (revman)","year":"2012","key":"B5"},{"key":"B6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.16368\/j.issn.1674-8999.2010.05.104","article-title":"Clinical research of intra-abdominal catheter drainage hot perfusion chemotherapy and shipi drink in treating cancerous ascites","volume":"25","author":"Cui","year":"2010","journal-title":"China J. Chin. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3892\/or.2012.1913","article-title":"B ultrasound - guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites","volume":"28","author":"Cui","year":"2012","journal-title":"Oncol. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.13862\/j.cnki.cn43-1446\/r.2016.04.012","article-title":"Clinical study of zhenwutan combined with hyperthermic intraperitoneal chemotherapy of paclitaxel in treating epithelial ovarian cancer with malignant ascites in middle and late period","volume":"22","author":"Dai","year":"2016","journal-title":"Guid. J. Traditional Chin. Med. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"B10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12904-019-0497-3","article-title":"Continuous low flow ascites drainage through the urinary bladder via the Alfapump system in palliative patients with malignant ascites","volume":"18","author":"Fotopoulou","year":"2019","journal-title":"BMC Palliat. Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.3969\/j.issn.1008-8849.2017.23.025","article-title":"Clinical observation of wenyang Jianpi Decoction assisted peritoneal heat perfusion chemotherapy in the treatment of secondary peritoneal effusion of advanced ovarian cancer","volume":"26","author":"Gao","year":"2017","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"volume-title":"Traditional Chinese Pharmacology","year":"2010","author":"Gao","key":"B12"},{"key":"B13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1471-2407-14-183","article-title":"GASTRICHIP:D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study","volume":"14","author":"Glehen","year":"2014","journal-title":"BMC cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3969\/j.issn.1009-0460.2013.05.020","article-title":"Advances of medical management in malignant ascites","volume":"18","author":"He","year":"2013","journal-title":"Chin. Clin. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jso.25453","article-title":"Palliation of malignant ascites","volume":"120","author":"Hodge","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1111\/ajco.13131","article-title":"Clinical efficacy of concurrent bevacizumab for malignant ascites in nonsquamous cell carcinoma of the lung","volume":"15","author":"Hsu","year":"2019","journal-title":"Asia. Pac. J. Clin. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.transci.2017.08.018","article-title":"CART: Cell-Free and concentrated ascites reinfusion therapy against malignancy-related ascites","volume":"56","author":"Ito","year":"2017","journal-title":"Transfus. Apher. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"832","DOI":"10.13633\/j.cnki.zjtcm.2019.11.032","article-title":"Observation on 40 cases of malignant peritoneal effusion treated by Wenyang Lishui Huayu prescription combined with peritoneal heat perfusion chemotherapy","volume":"54","author":"Jiang","year":"2019","journal-title":"Zhejiang J. Tradit. Chin. Med."},{"key":"B20","first-page":"512","article-title":"Research overview of TCM treatment of malignant ascites","volume":"37","author":"Kong","year":"2021","journal-title":"J. Pract. Tradit. Chin. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jamcollsurg.2006.12.048","article-title":"Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures","volume":"204","author":"Levine","year":"2007","journal-title":"J. Am. Coll. Surg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.3969\/j.issn.1000-8179.2012.22.012","article-title":"Cytoreductive surgery plus hyperthermic intra-peritoneal chemotherapy for peritoneal carcinomatosis from gastric cancer","volume":"39","author":"Li","year":"2012","journal-title":"Chin. J. Clin. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3969\/j.issn.1002-2619.2020.10.021","article-title":"Clinical observation on the treatment of malignant peritoneal effusion with drainage plaster combined with peritoneal heat perfusion chemotherapy","volume":"42","author":"Li","year":"2020","journal-title":"Hebei J. Tradit. Chin. Med."},{"key":"B24","first-page":"44","article-title":"Observation on the curative effect of peritoneal heat perfusion combined with Fuzheng Yaxue Decoction on malignant ascites","volume":"17","author":"Li","year":"2020","journal-title":"Diabetes World"},{"volume-title":"Clinical observation on the treatment of malignant ascites with spleen-kidney-Yang deficiency by Wenyang Lishi Prescription combined with peritoneal circulation heat perfusion chemotherapy","year":"2021","author":"Li","key":"B25"},{"key":"B26","doi-asserted-by":"publisher","first-page":"10936","DOI":"10.3748\/wjg.v21.i39.10936","article-title":"Evaluation and treatment of malignant ascites secondary to gastric cancer","volume":"21","author":"Maeda","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3969\/j.issn.1009-4393.2020.11.060","article-title":"Clinical observation of Yishen Sanjie Pill combined with peritoneal heat perfusion chemotherapy in the treatment of malignant ascites secondary to advanced gynecological malignant tumor","volume":"26","author":"Mei","year":"2020","journal-title":"Contemp. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3969\/j.issn.1004-2814.2017.10.041","article-title":"Observation on the curative effect of peritoneal heat perfusion chemotherapy combined with Fuzhengquxie Anti-cancer prescription in treating malignant ascites","volume":"33","author":"Pan","year":"2017","journal-title":"J. Pract. Traditional Chin. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3969\/j.issn.1003-8914.2017.06.036","article-title":"Clinical study on invigorating spleen for diuresis and activating blood circulation prescription combined with deep hyperthermia in the treatment of malignant ascites","volume":"32","author":"Peng","year":"2017","journal-title":"Guangming J. Chin. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1157\/13101085","article-title":"Practical considerations on detection of publication bias","volume":"20","author":"P\u00e9rez","year":"2006","journal-title":"Gac. Sanit."},{"volume-title":"Chinese Materia Medica","year":"2006","author":"Qiu","key":"B31"},{"key":"B32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.23736\/S0026-4733.18.07649-6","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: morbidity and postoperative outcomes","volume":"74","author":"Robella","year":"2019","journal-title":"Minerva Chir."},{"key":"B33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.13193\/j.issn.1673-7717.2021.10.054","article-title":"Clinical efficacy and safety of danghuang kangai decoction combined with intracavitary hyperthermic perfusion chemotherapy for ovarian cancer with peritoneal effusion","volume":"39","author":"Rui","year":"2021","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3969\/j.issn.1005-4561.2019.08.007","article-title":"Clinical observation on the treatment of advanced ovarian cancer complicated with malignant peritoneal effusion by self-designed detoxification and cancer suppression decoction combined with peritoneal heat perfusion chemotherapy","volume":"29","author":"Shao","year":"2019","journal-title":"Zhejiang J. Integr. Tradit. Chin. West. Med."},{"volume-title":"The Chinese pharmacopoeia, the first part","year":"2015","key":"B35"},{"key":"B36","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1001\/archsurg.2012.988","article-title":"Initial experience with hyperthermic intraperitoneal chemotherapy","volume":"147","author":"Turrini","year":"2012","journal-title":"Arch. Surg."},{"volume-title":"Systematic evaluation and mesh meta-analysis of Chinese medicine injection combined with cisplatin in the treatment of cancer ascites","year":"2020","author":"Wang","key":"B37"},{"key":"B38","first-page":"71","article-title":"Clinical observation of self-made tumor prescription combined with peritoneal heat perfusion chemotherapy in the treatment of ovarian cancer ascites","volume":"6","author":"Wen","year":"2015","journal-title":"Chin. Manip. Rehabilitation Med."},{"key":"B39","first-page":"3112","article-title":"Analysis of the TCM syndromes of malignant ascites","volume":"30","author":"Wu","year":"2015","journal-title":"China J. Traditional Chin. Med. Pharm."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.3969\/j.issn.1006-6233.2016.10.065","article-title":"Clinical effect of peritoneal heat perfusion chemotherapy combined with Traditional Chinese medicine on malignant ascites","volume":"22","author":"Wu","year":"2016","journal-title":"Hebei Med."},{"key":"B41","first-page":"322","volume-title":"Clinical diagnosis and treatment guidelines: tumour fascicule","author":"Xu","year":"2005"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1007\/s13277-015-4198-0","article-title":"The clinical significance of vascular endothelial growth factor in malignant ascites","volume":"37","author":"Zhan","year":"2016","journal-title":"Tumour Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.13862\/j.cnki.cn43-1446\/r.2018.05.019","article-title":"Effect of external application of Shipi Xiaoshui Ointment combined with abdominal heat perfusion chemotherapy on patients with ascites with peritoneal metastasis of advanced gastric cancer","volume":"24","author":"Zhang","year":"2018","journal-title":"Guid. J. Tradit. Chin. Med. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"11347","DOI":"10.3748\/wjg.v20.i32.11347","article-title":"MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.13192\/j.issn.1000-1719.2017.10.025","article-title":"Clinical research of longxie xiaoshui ointment for external application plus hyperthermic intraperitoneal chemotherapy in treatment of patients with malignant ascites","volume":"44","author":"Zhang","year":"2017","journal-title":"Liaoning J. Tradit. Chin. Med."},{"key":"B46","first-page":"157","article-title":"Clinical observation and study of mechanism of applying wenyang lishui decoction combined with intraperitoneal chemotherapy in the treatment of ovarian cancer patients with ascites hyperthermic perfusion","volume":"36","author":"Zhang","year":"2018","journal-title":"J. Sichuan Traditional Chin. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3969\/j.issn.1674-1749.2019.11.020","article-title":"Discussion on the application of huoxuelishui method in cancer ascites from the perspective of \" when blood does not move, it becomes water","volume":"12","author":"Zhang","year":"2019","journal-title":"Glob. Tradit. Chin. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.16448\/j.cjtcm.2020.1025","article-title":"Effects of self-made jianpi buqi lishui recipe combined with intraperitoneal hyperthermic chemotherapy on serum VEGF and MMPS levels in patients with malignant ascites","volume":"32","author":"Zhang","year":"2020","journal-title":"Clin. J. Traditional Chin. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.938472\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T04:59:48Z","timestamp":1661749188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.938472\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":48,"alternative-id":["10.3389\/fphar.2022.938472"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.938472","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"article-number":"938472"}}